SkyCell

PharmaLifeScience News

...

Top pharmaceutical and IT companies threaten to quit Ireland if ban on ‘forever chemicals’ is introduced
Leading pharmaceutical and IT companies have said they will quit Ireland if a proposed ban on so-called forever chemicals is introduced.
READ MORE
...

How will SearchGPT impact pharma and healthcare?

The recent launch of SearchGPT by OpenAI marks the beginning of a significant shift in how information is searched and consumed for pharma and healthcare industry leaders.

READ MORE
...

Clinical trial trends in 2025: Investment headwinds, wearables, and targeted AI uses
With clinical trials facing multiple challenges, digital solutions could provide the answer. We identify the key trends to watch in 2025.
READ MORE

Ensuring packaging integrity of frozen biopharmaceutical products

WuXi Biologics to sell Ireland-based vaccine site to MSD for $500m

New research reframes the debate on drug development costs

Manufacturers can streamline and speed the batch release process by embracing these three digital fundamentals

Lilly trims sales forecast on weaker obesity/diabetes growth

How GenAI will transform life sciences in 2025

The biomedical engineer championing the next stage of women’s healthcare

2025 Life sciences real estate predictions

Candid Therapeutics signs $925m T cell engager deal with WuXi Biologics

The great ISO IDMP implementation challenge: Are companies finally ready?

Roche gains rights to Innovent Biologics’ ADC candidate in deal worth over $1bn

Abu Dhabi Stem Cells Center develops clinical-grade iPSCs

BrainChild Bio advances development of CAR T therapy for pediatric brain tumors

GSK bags breakthrough status for bone cancer drug

EMA gives OMPD to Actuate’s pancreatic cancer therapy

AMD to invest $20m in Absci to boost AI drug discovery tech

Verdiva Bio raises $411m for obesity pipeline

Pharma trends and predictions for 2025: An incoming CEO’s perspective

Expert advice on how to dance yourself fit and happy as Dancing with the Stars returns

Capricor files cell therapy for DMD cardiomyopathy with FDA

Amgen’s lung cancer treatment gets conditional approval
Ellab